Home › Funds › Parkman Healthcare Partners LLC › PTCT

Parkman Healthcare Partners LLC position in PTCT

PTC THERAPEUTICS INC · Health Care

Parkman Healthcare Partners LLC reported holding 700,393 shares of PTCT (PTC THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$45.4M, representing 4.10% of its reported portfolio and ranking #1 among its reported holdings. Parkman Healthcare Partners LLC has disclosed PTCT holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)700.39K sh
Reported value held$45.37M
Portfolio Weight4.10%
First reportedQ3 2024
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Parkman Healthcare Partners LLC's PTCT position evolved

Parkman Healthcare Partners LLC first disclosed a stake in PTCT in Q3 2024 at 195,000 shares (US$7.2M). The position peaked in Q3 2026 at 700,393 shares, worth US$45.4M. Across 9 filings, Parkman Healthcare Partners LLC increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 700,393 shares valued at US$45.4M — an increase of 264,702 shares quarter over quarter.. Notable position changes include a 58% increase in Q1 2025 (shares fell 4% over the following quarter), a 169% increase in Q1 2026 (shares rose 20% over the following quarter), a 61% increase in Q3 2026 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 195.00K $7.23M New
Q4 2024 177.37K $8.01M Reduce
Q1 2025 280.31K $14.28M Add
Q2 2025 181.64K $8.87M Reduce
Q3 2025 202.36K $12.42M Add
Q4 2025 160.18K $12.17M Reduce
Q1 2026 431.36K $29.39M Add
Q2 2026 435.69K $35.54M Add
Q3 2026 700.39K $45.37M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PTCT and 13F data

PTCT (PTC THERAPEUTICS INC) is a Health Care company. 42 other funds we track also report a position in PTCT — the largest reported positions include TORONTO DOMINION BANK (US$176.7M), WESTFIELD CAPITAL MANAGEMENT CO LP (US$174.9M), TANG CAPITAL MANAGEMENT LLC (US$122.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PTCT

All PTCT fund holders →

FAQ

How long has Parkman Healthcare Partners LLC held PTCT?

Parkman Healthcare Partners LLC has disclosed PTCT holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Parkman Healthcare Partners LLC's current position in PTCT?

As of Q3 2026, Parkman Healthcare Partners LLC holds 700.39K shares of PTCT (PTC THERAPEUTICS INC), valued at $45.37M, representing 4.10% of its reported portfolio and ranking #1.

Has Parkman Healthcare Partners LLC been buying or selling PTCT?

In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC increased its position in PTCT. The position peaked in Q3 2026 at 700.39K shares.

Which other funds hold PTCT?

Other major institutional holders of PTCT include TORONTO DOMINION BANK, WESTFIELD CAPITAL MANAGEMENT CO LP, TANG CAPITAL MANAGEMENT LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.